Cargando…

Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”

Detalles Bibliográficos
Autores principales:	Curioni-Fontecedro, A., Pitocco, R., Schoenewolf, N. L., Holzmann, D., Soldini, D., Dummer, R., Calvieri, S., Moch, H., Fitsche, A., Mihic-Probst, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679846/ https://www.ncbi.nlm.nih.gov/pubmed/31428638 http://dx.doi.org/10.1155/2019/5256364

Ejemplares similares

Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
por: Curioni-Fontecedro, A., et al.
Publicado: (2015)

Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients
por: Curioni-Fontecedro, Alessandra, et al.
Publicado: (2011)

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)

Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
por: Freiberger, Sandra N., et al.
Publicado: (2022)

MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer
por: von Boehmer, Lotta, et al.
Publicado: (2011)

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer
por: Chen, Xinfeng, et al.
Publicado: (2017)

Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)

Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

Correction to: MAGE‑C2/CT10 promotes growth and metastasis through upregulating c‑Myc expression in prostate cancer
por: Qiu, Jun, et al.
Publicado: (2020)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017)

RETRACTED ARTICLE: MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer
por: Qiu, Jun, et al.
Publicado: (2020)

Retraction Note: MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer
por: Qiu, Jun, et al.
Publicado: (2023)

Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008)

Miltiwire proportional chambers MAGE spectrometer
por: Gusev, K E, et al.
Publicado: (2003)

CRMAGE: CRISPR Optimized MAGE Recombineering
por: Ronda, Carlotta, et al.
Publicado: (2016)

MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)

Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines
por: de Carvalho, Fabricio, et al.
Publicado: (2011)

Centrosomal Localisation of the Cancer/Testis (CT) Antigens NY-ESO-1 and MAGE-C1 Is Regulated by Proteasome Activity in Tumour Cells
por: Pagotto, Anna, et al.
Publicado: (2013)

TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets
por: Straetemans, Trudy, et al.
Publicado: (2012)

Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4(+) and CD8(+) T-cell responses in multiple myeloma patients
por: Reinhard, H, et al.
Publicado: (2014)

Correction: Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

The XBabelPhish MAGE-ML and XML Translator
por: Maier, Don, et al.
Publicado: (2008)

Expression of MAGE‐1 Gene by Esophageal Carcinomas
por: Toh, Yuji, et al.
Publicado: (1995)

The Story of the Magee Equations: The Ultimate in Applied Immunohistochemistry
por: Bhargava, Rohit, et al.
Publicado: (2023)

The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer
por: Bhargava, Rohit, et al.
Publicado: (2020)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
por: Inaoka, Riguel J, et al.
Publicado: (2011)

MAGE-C2在肺腺癌中的表达及临床意义
Publicado: (2016)

Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.
por: Park, Myeng-Sun, et al.
Publicado: (2002)

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative()()
por: Lenggenhager, Daniela, et al.
Publicado: (2014)

Functional interaction between co-expressed MAGE-A proteins
por: Laiseca, Julieta E., et al.
Publicado: (2017)

Demethylation of MAGE promoters during gastric cancer progression
por: Honda, T, et al.
Publicado: (2004)

Genome-scale promoter engineering by Co-Selection MAGE
por: Wang, Harris H., et al.
Publicado: (2012)

MAGE genes: Prognostic indicators in AL amyloidosis patients
por: Liu, Yang, et al.
Publicado: (2019)

Analysis of the function of MAGE-A in esophageal carcinoma by bioinformatics
por: Chen, Xiaohua, et al.
Publicado: (2019)

The multi-mode acoustic gravitational wave experiment: MAGE
por: Campbell, William M., et al.
Publicado: (2023)

Expanding the landscape of TCR gene therapy targeting MAGE
por: Mao, Zhiyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i21453lfdqkm21ov10n88kh43n